Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis

BACKGROUND: Nafamostat mesilate (NM), a broad-spectrum and potent serine protease inhibitor, can be used as an anticoagulant during extracorporeal circulation, as well as a promising drug effective against coronavirus disease 2019 (COVID-19). We conducted a systematic meta-analysis to evaluate the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yao, Shao, Yiming, Liu, Yuchun, Yang, Ruoxuan, Liao, Shuanglin, Yang, Shuai, Xu, Mingwei, He, Junbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359194/
https://www.ncbi.nlm.nih.gov/pubmed/35930302
http://dx.doi.org/10.1080/0886022X.2022.2105233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359194/
https://www.ncbi.nlm.nih.gov/pubmed/35930302
http://dx.doi.org/10.1080/0886022X.2022.2105233

Ejemplares similares